Yung Cheng Wu - Net Worth and Insider Trading

Yung Cheng Wu Net Worth

The estimated net worth of Yung Cheng Wu is at least $63,818 dollars as of 2024-09-21. Yung Cheng Wu is the Director of Antibe Therapeutics Inc and owns about 216,333 shares of Antibe Therapeutics Inc (TSX:ATE) stock worth over $63,818. Details can be seen in Yung Cheng Wu's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yung Cheng Wu has not made any transactions after 2021-11-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Yung Cheng Wu

To

Yung Cheng Wu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Yung Cheng Wu owns 1 companies in total, including Antibe Therapeutics Inc (TSX:ATE) .

Click here to see the complete history of Yung Cheng Wu’s form 4 insider trades.

Insider Ownership Summary of Yung Cheng Wu

Ticker Comapny Transaction Date Type of Owner
TSX:ATE Antibe Therapeutics Inc 2021-11-01 Director

Yung Cheng Wu Latest Holdings Summary

Yung Cheng Wu currently owns a total of 1 stock. Yung Cheng Wu owns 216,333 shares of Antibe Therapeutics Inc (TSX:ATE) as of November 1, 2021, with a value of $63,818.

Latest Holdings of Yung Cheng Wu

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:ATE Antibe Therapeutics Inc 2021-11-01 216,333 0.30 63,818

Holding Weightings of Yung Cheng Wu


Yung Cheng Wu Form 4 Trading Tracker

According to the SEC Form 4 filings, Yung Cheng Wu has made a total of 8 transactions in Antibe Therapeutics Inc (TSX:ATE) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Antibe Therapeutics Inc is the acquisition of 25,000 shares on November 1, 2021, which cost Yung Cheng Wu around $22,250.

Insider Trading History of Yung Cheng Wu

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Yung Cheng Wu Trading Performance

GuruFocus tracks the stock performance after each of Yung Cheng Wu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yung Cheng Wu is -28.57%. GuruFocus also compares Yung Cheng Wu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yung Cheng Wu within 3 months outperforms 0 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Yung Cheng Wu's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Yung Cheng Wu

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -31.63 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -29.45 LIMIT LIMIT LIMIT LIMIT LIMIT

Yung Cheng Wu Ownership Network

Ownership Network List of Yung Cheng Wu

No Data

Ownership Network Relation of Yung Cheng Wu

Insider Network Chart

Yung Cheng Wu Owned Company Details

What does Antibe Therapeutics Inc do?

Who are the key executives at Antibe Therapeutics Inc?

Yung Cheng Wu is the Director of Antibe Therapeutics Inc. Other key executives at Antibe Therapeutics Inc include Director & Director or Senior Officer of 10% Security Holder & Senior Officer John Lawrence Wallace , Senior Officer Joseph Stauffer , and Senior Officer Scott Wilson Curtis .

Antibe Therapeutics Inc (TSX:ATE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Antibe Therapeutics Inc (TSX:ATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antibe Therapeutics Inc (TSX:ATE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Antibe Therapeutics Inc (TSX:ATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Antibe Therapeutics Inc Insider Transactions

No Available Data

Yung Cheng Wu Mailing Address

Above is the net worth, insider trading, and ownership report for Yung Cheng Wu. Currently GuruFocus does not have mailing address information for Yung Cheng Wu.

Discussions on Yung Cheng Wu

No discussions yet.